Application Nr Approved Date Route Status External Links
ANDA076174 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Etodolac Extended-Release Tablets And Other Treatment Options Before Deciding To Use Etodolac Extended-Release Tablets. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (See Warnings ). Etodolac Extended-Release Tablets Are Indicated: For Relief Of Signs And Symptoms Of Juvenile Arthritis For Relief Of The Signs And Symptoms Of Rheumatoid Arthritis For Relief Of The Signs And Symptoms Of Osteoarthritis

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Etodolac ETODOLAC ZINC3642

Comments